8-K
Current Report
Alaunos Therapeutics, Inc. Filed Acc 0001213900-20-043385
Delisting notice · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Other events
- Item 3.01 Notice of delisting or failure to meet a listing standard
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.07 Submission of matters to a vote of security holders
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading ea131880-8k_ziopharm.htm…